nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—obesity	0.276	0.678	CbGaD
Pomalidomide—PTGS2—obesity	0.131	0.322	CbGaD
Pomalidomide—CYP1A2—Phentermine—obesity	0.05	0.153	CbGbCtD
Pomalidomide—CYP1A2—Phenylpropanolamine—obesity	0.0477	0.146	CbGbCtD
Pomalidomide—CYP1A2—Bupropion—obesity	0.0425	0.13	CbGbCtD
Pomalidomide—CYP3A4—Sibutramine—obesity	0.0346	0.106	CbGbCtD
Pomalidomide—CYP1A2—Cimetidine—obesity	0.0312	0.0954	CbGbCtD
Pomalidomide—ABCB1—Cimetidine—obesity	0.0273	0.0835	CbGbCtD
Pomalidomide—CYP3A4—Benzphetamine—obesity	0.0262	0.0801	CbGbCtD
Pomalidomide—CYP3A4—Bupropion—obesity	0.0223	0.0681	CbGbCtD
Pomalidomide—CYP3A4—Orlistat—obesity	0.0182	0.0555	CbGbCtD
Pomalidomide—CYP3A4—Cimetidine—obesity	0.0164	0.05	CbGbCtD
Pomalidomide—CYP3A4—Topiramate—obesity	0.0107	0.0327	CbGbCtD
Pomalidomide—PTGS2—ovarian follicle—obesity	0.00429	0.153	CbGeAlD
Pomalidomide—CRBN—islet of Langerhans—obesity	0.0022	0.0788	CbGeAlD
Pomalidomide—CRBN—respiratory system—obesity	0.00208	0.0744	CbGeAlD
Pomalidomide—CRBN—adrenal cortex—obesity	0.00175	0.0624	CbGeAlD
Pomalidomide—CRBN—pituitary gland—obesity	0.00141	0.0504	CbGeAlD
Pomalidomide—CRBN—adipose tissue—obesity	0.0014	0.0502	CbGeAlD
Pomalidomide—CRBN—digestive system—obesity	0.00132	0.0473	CbGeAlD
Pomalidomide—CRBN—adrenal gland—obesity	0.00126	0.045	CbGeAlD
Pomalidomide—CRBN—endocrine gland—obesity	0.00109	0.0391	CbGeAlD
Pomalidomide—CRBN—liver—obesity	0.000985	0.0352	CbGeAlD
Pomalidomide—Thalidomide—TNF—obesity	0.000954	0.329	CrCbGaD
Pomalidomide—PTGS2—gall bladder—obesity	0.000915	0.0327	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—obesity	0.000756	0.261	CrCbGaD
Pomalidomide—Thalidomide—CYP2E1—obesity	0.000735	0.254	CrCbGaD
Pomalidomide—CYP1A2—respiratory system—obesity	0.000684	0.0244	CbGeAlD
Pomalidomide—PTGS2—islet of Langerhans—obesity	0.0006	0.0214	CbGeAlD
Pomalidomide—PTGS2—respiratory system—obesity	0.000566	0.0202	CbGeAlD
Pomalidomide—PTGS2—adrenal cortex—obesity	0.000475	0.017	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—obesity	0.000453	0.156	CrCbGaD
Pomalidomide—CYP1A2—digestive system—obesity	0.000435	0.0155	CbGeAlD
Pomalidomide—PTGS2—cardiovascular system—obesity	0.000434	0.0155	CbGeAlD
Pomalidomide—Infestation—Orlistat—obesity	0.000401	0.00309	CcSEcCtD
Pomalidomide—Fatigue—Cimetidine—obesity	0.000399	0.00308	CcSEcCtD
Pomalidomide—Breast disorder—Bupropion—obesity	0.000397	0.00305	CcSEcCtD
Pomalidomide—Constipation—Cimetidine—obesity	0.000396	0.00305	CcSEcCtD
Pomalidomide—Weight increased—Sibutramine—obesity	0.000396	0.00305	CcSEcCtD
Pomalidomide—Renal failure—Orlistat—obesity	0.000394	0.00304	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Orlistat—obesity	0.000393	0.00303	CcSEcCtD
Pomalidomide—Hyperglycaemia—Sibutramine—obesity	0.000393	0.00302	CcSEcCtD
Pomalidomide—Nasopharyngitis—Bupropion—obesity	0.000393	0.00302	CcSEcCtD
Pomalidomide—Pneumonia—Sibutramine—obesity	0.00039	0.00301	CcSEcCtD
Pomalidomide—Musculoskeletal pain—Topiramate—obesity	0.00039	0.003	CcSEcCtD
Pomalidomide—Urinary tract infection—Orlistat—obesity	0.00039	0.003	CcSEcCtD
Pomalidomide—Muscular weakness—Bupropion—obesity	0.000387	0.00298	CcSEcCtD
Pomalidomide—Dizziness—Phenylpropanolamine—obesity	0.000387	0.00298	CcSEcCtD
Pomalidomide—Pulmonary embolism—Topiramate—obesity	0.000385	0.00297	CcSEcCtD
Pomalidomide—PTGS2—pituitary gland—obesity	0.000384	0.0137	CbGeAlD
Pomalidomide—Diarrhoea—Phentermine—obesity	0.000383	0.00295	CcSEcCtD
Pomalidomide—PTGS2—adipose tissue—obesity	0.000382	0.0137	CbGeAlD
Pomalidomide—Feeling abnormal—Cimetidine—obesity	0.000382	0.00294	CcSEcCtD
Pomalidomide—Renal failure—Sibutramine—obesity	0.000382	0.00294	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Sibutramine—obesity	0.000381	0.00293	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Orlistat—obesity	0.000379	0.00292	CcSEcCtD
Pomalidomide—Urinary tract infection—Sibutramine—obesity	0.000377	0.0029	CcSEcCtD
Pomalidomide—Depressed level of consciousness—Topiramate—obesity	0.000372	0.00286	CcSEcCtD
Pomalidomide—Vomiting—Phenylpropanolamine—obesity	0.000372	0.00286	CcSEcCtD
Pomalidomide—ABCB1—islet of Langerhans—obesity	0.000371	0.0133	CbGeAlD
Pomalidomide—Dizziness—Phentermine—obesity	0.00037	0.00285	CcSEcCtD
Pomalidomide—Rash—Phenylpropanolamine—obesity	0.000369	0.00284	CcSEcCtD
Pomalidomide—Dermatitis—Phenylpropanolamine—obesity	0.000368	0.00284	CcSEcCtD
Pomalidomide—Body temperature increased—Cimetidine—obesity	0.000366	0.00282	CcSEcCtD
Pomalidomide—Epistaxis—Sibutramine—obesity	0.000366	0.00282	CcSEcCtD
Pomalidomide—Bronchitis—Bupropion—obesity	0.000365	0.00281	CcSEcCtD
Pomalidomide—Neuropathy—Topiramate—obesity	0.000362	0.00279	CcSEcCtD
Pomalidomide—Pancytopenia—Bupropion—obesity	0.00036	0.00277	CcSEcCtD
Pomalidomide—PTGS2—digestive system—obesity	0.00036	0.0129	CbGeAlD
Pomalidomide—CYP1A2—endocrine gland—obesity	0.000359	0.0128	CbGeAlD
Pomalidomide—Vomiting—Phentermine—obesity	0.000356	0.00274	CcSEcCtD
Pomalidomide—Urinary tract disorder—Orlistat—obesity	0.000356	0.00274	CcSEcCtD
Pomalidomide—Oedema peripheral—Orlistat—obesity	0.000355	0.00273	CcSEcCtD
Pomalidomide—Urethral disorder—Orlistat—obesity	0.000353	0.00272	CcSEcCtD
Pomalidomide—Rash—Phentermine—obesity	0.000353	0.00272	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Bupropion—obesity	0.000353	0.00272	CcSEcCtD
Pomalidomide—Dermatitis—Phentermine—obesity	0.000353	0.00271	CcSEcCtD
Pomalidomide—Headache—Phentermine—obesity	0.000351	0.0027	CcSEcCtD
Pomalidomide—ABCB1—respiratory system—obesity	0.00035	0.0125	CbGeAlD
Pomalidomide—Nausea—Phenylpropanolamine—obesity	0.000347	0.00267	CcSEcCtD
Pomalidomide—Weight increased—Bupropion—obesity	0.000345	0.00266	CcSEcCtD
Pomalidomide—Weight decreased—Bupropion—obesity	0.000343	0.00264	CcSEcCtD
Pomalidomide—Oedema peripheral—Sibutramine—obesity	0.000343	0.00264	CcSEcCtD
Pomalidomide—PTGS2—adrenal gland—obesity	0.000343	0.0123	CbGeAlD
Pomalidomide—Hyperglycaemia—Bupropion—obesity	0.000342	0.00264	CcSEcCtD
Pomalidomide—Hypersensitivity—Cimetidine—obesity	0.000341	0.00263	CcSEcCtD
Pomalidomide—Pneumonia—Bupropion—obesity	0.00034	0.00262	CcSEcCtD
Pomalidomide—Infestation—Bupropion—obesity	0.000338	0.0026	CcSEcCtD
Pomalidomide—Infestation NOS—Bupropion—obesity	0.000338	0.0026	CcSEcCtD
Pomalidomide—Diarrhoea—Diethylpropion—obesity	0.000333	0.00256	CcSEcCtD
Pomalidomide—Nausea—Phentermine—obesity	0.000333	0.00256	CcSEcCtD
Pomalidomide—Asthenia—Cimetidine—obesity	0.000332	0.00256	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Bupropion—obesity	0.000332	0.00255	CcSEcCtD
Pomalidomide—Urinary tract infection—Bupropion—obesity	0.000329	0.00253	CcSEcCtD
Pomalidomide—Mediastinal disorder—Orlistat—obesity	0.000325	0.0025	CcSEcCtD
Pomalidomide—CYP1A2—liver—obesity	0.000324	0.0116	CbGeAlD
Pomalidomide—Dizziness—Diethylpropion—obesity	0.000322	0.00248	CcSEcCtD
Pomalidomide—Epistaxis—Bupropion—obesity	0.000319	0.00246	CcSEcCtD
Pomalidomide—Diarrhoea—Cimetidine—obesity	0.000317	0.00244	CcSEcCtD
Pomalidomide—Angiopathy—Sibutramine—obesity	0.000316	0.00243	CcSEcCtD
Pomalidomide—Mental disorder—Orlistat—obesity	0.000315	0.00243	CcSEcCtD
Pomalidomide—CYP3A4—digestive system—obesity	0.000315	0.0112	CbGeAlD
Pomalidomide—Malnutrition—Orlistat—obesity	0.000313	0.00241	CcSEcCtD
Pomalidomide—Chills—Sibutramine—obesity	0.000313	0.00241	CcSEcCtD
Pomalidomide—Vomiting—Diethylpropion—obesity	0.00031	0.00238	CcSEcCtD
Pomalidomide—Rash—Diethylpropion—obesity	0.000307	0.00236	CcSEcCtD
Pomalidomide—Dermatitis—Diethylpropion—obesity	0.000307	0.00236	CcSEcCtD
Pomalidomide—Dizziness—Cimetidine—obesity	0.000306	0.00236	CcSEcCtD
Pomalidomide—Headache—Diethylpropion—obesity	0.000305	0.00235	CcSEcCtD
Pomalidomide—Malnutrition—Sibutramine—obesity	0.000303	0.00234	CcSEcCtD
Pomalidomide—Back pain—Orlistat—obesity	0.000303	0.00233	CcSEcCtD
Pomalidomide—Muscle spasms—Orlistat—obesity	0.000301	0.00232	CcSEcCtD
Pomalidomide—Urinary tract disorder—Bupropion—obesity	0.0003	0.00231	CcSEcCtD
Pomalidomide—Oedema peripheral—Bupropion—obesity	0.000299	0.0023	CcSEcCtD
Pomalidomide—Connective tissue disorder—Bupropion—obesity	0.000299	0.0023	CcSEcCtD
Pomalidomide—Urethral disorder—Bupropion—obesity	0.000298	0.00229	CcSEcCtD
Pomalidomide—PTGS2—endocrine gland—obesity	0.000297	0.0106	CbGeAlD
Pomalidomide—Vomiting—Cimetidine—obesity	0.000295	0.00227	CcSEcCtD
Pomalidomide—ABCB1—adrenal cortex—obesity	0.000294	0.0105	CbGeAlD
Pomalidomide—Back pain—Sibutramine—obesity	0.000293	0.00226	CcSEcCtD
Pomalidomide—Rash—Cimetidine—obesity	0.000292	0.00225	CcSEcCtD
Pomalidomide—Dermatitis—Cimetidine—obesity	0.000292	0.00225	CcSEcCtD
Pomalidomide—Muscle spasms—Sibutramine—obesity	0.000292	0.00225	CcSEcCtD
Pomalidomide—Headache—Cimetidine—obesity	0.00029	0.00223	CcSEcCtD
Pomalidomide—Nausea—Diethylpropion—obesity	0.000289	0.00223	CcSEcCtD
Pomalidomide—Tremor—Sibutramine—obesity	0.000284	0.00219	CcSEcCtD
Pomalidomide—Cardiac disorder—Bupropion—obesity	0.000282	0.00217	CcSEcCtD
Pomalidomide—Vertigo—Orlistat—obesity	0.000282	0.00217	CcSEcCtD
Pomalidomide—Hyponatraemia—Topiramate—obesity	0.000281	0.00216	CcSEcCtD
Pomalidomide—Anaemia—Sibutramine—obesity	0.00028	0.00216	CcSEcCtD
Pomalidomide—Pain in extremity—Topiramate—obesity	0.00028	0.00215	CcSEcCtD
Pomalidomide—Angiopathy—Bupropion—obesity	0.000276	0.00212	CcSEcCtD
Pomalidomide—Nausea—Cimetidine—obesity	0.000275	0.00212	CcSEcCtD
Pomalidomide—Mediastinal disorder—Bupropion—obesity	0.000274	0.00211	CcSEcCtD
Pomalidomide—Cough—Orlistat—obesity	0.000274	0.00211	CcSEcCtD
Pomalidomide—Chills—Bupropion—obesity	0.000273	0.0021	CcSEcCtD
Pomalidomide—Vertigo—Sibutramine—obesity	0.000273	0.0021	CcSEcCtD
Pomalidomide—Leukopenia—Sibutramine—obesity	0.000272	0.00209	CcSEcCtD
Pomalidomide—ABCB1—cardiovascular system—obesity	0.000268	0.00959	CbGeAlD
Pomalidomide—PTGS2—liver—obesity	0.000268	0.00959	CbGeAlD
Pomalidomide—Mental disorder—Bupropion—obesity	0.000266	0.00205	CcSEcCtD
Pomalidomide—Urinary retention—Topiramate—obesity	0.000266	0.00205	CcSEcCtD
Pomalidomide—Anxiety—Orlistat—obesity	0.000266	0.00205	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000265	0.00204	CcSEcCtD
Pomalidomide—Cough—Sibutramine—obesity	0.000265	0.00204	CcSEcCtD
Pomalidomide—Malnutrition—Bupropion—obesity	0.000264	0.00204	CcSEcCtD
Pomalidomide—Blood creatinine increased—Topiramate—obesity	0.000262	0.00202	CcSEcCtD
Pomalidomide—Dehydration—Topiramate—obesity	0.00026	0.002	CcSEcCtD
Pomalidomide—CYP3A4—endocrine gland—obesity	0.00026	0.0093	CbGeAlD
Pomalidomide—Arthralgia—Sibutramine—obesity	0.000258	0.00199	CcSEcCtD
Pomalidomide—Anxiety—Sibutramine—obesity	0.000257	0.00198	CcSEcCtD
Pomalidomide—Back pain—Bupropion—obesity	0.000256	0.00197	CcSEcCtD
Pomalidomide—Hypokalaemia—Topiramate—obesity	0.000255	0.00196	CcSEcCtD
Pomalidomide—Muscle spasms—Bupropion—obesity	0.000254	0.00196	CcSEcCtD
Pomalidomide—Infection—Orlistat—obesity	0.000254	0.00196	CcSEcCtD
Pomalidomide—Breast disorder—Topiramate—obesity	0.000253	0.00195	CcSEcCtD
Pomalidomide—Nervous system disorder—Orlistat—obesity	0.000251	0.00193	CcSEcCtD
Pomalidomide—Nasopharyngitis—Topiramate—obesity	0.00025	0.00193	CcSEcCtD
Pomalidomide—Confusional state—Sibutramine—obesity	0.00025	0.00192	CcSEcCtD
Pomalidomide—Skin disorder—Orlistat—obesity	0.000248	0.00191	CcSEcCtD
Pomalidomide—Tremor—Bupropion—obesity	0.000248	0.00191	CcSEcCtD
Pomalidomide—Hyperhidrosis—Orlistat—obesity	0.000247	0.0019	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Topiramate—obesity	0.000247	0.0019	CcSEcCtD
Pomalidomide—Muscular weakness—Topiramate—obesity	0.000247	0.0019	CcSEcCtD
Pomalidomide—Infection—Sibutramine—obesity	0.000246	0.00189	CcSEcCtD
Pomalidomide—Anaemia—Bupropion—obesity	0.000244	0.00188	CcSEcCtD
Pomalidomide—Thrombocytopenia—Sibutramine—obesity	0.000242	0.00187	CcSEcCtD
Pomalidomide—Skin disorder—Sibutramine—obesity	0.00024	0.00185	CcSEcCtD
Pomalidomide—Hyperhidrosis—Sibutramine—obesity	0.000239	0.00184	CcSEcCtD
Pomalidomide—Vertigo—Bupropion—obesity	0.000238	0.00183	CcSEcCtD
Pomalidomide—ABCB1—pituitary gland—obesity	0.000237	0.00849	CbGeAlD
Pomalidomide—Leukopenia—Bupropion—obesity	0.000237	0.00182	CcSEcCtD
Pomalidomide—ABCB1—adipose tissue—obesity	0.000237	0.00846	CbGeAlD
Pomalidomide—CYP3A4—liver—obesity	0.000234	0.00838	CbGeAlD
Pomalidomide—Musculoskeletal discomfort—Orlistat—obesity	0.000233	0.00179	CcSEcCtD
Pomalidomide—Bronchitis—Topiramate—obesity	0.000233	0.00179	CcSEcCtD
Pomalidomide—Insomnia—Orlistat—obesity	0.000231	0.00178	CcSEcCtD
Pomalidomide—Cough—Bupropion—obesity	0.000231	0.00178	CcSEcCtD
Pomalidomide—Pancytopenia—Topiramate—obesity	0.00023	0.00177	CcSEcCtD
Pomalidomide—Neutropenia—Topiramate—obesity	0.000226	0.00174	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Sibutramine—obesity	0.000226	0.00174	CcSEcCtD
Pomalidomide—Arthralgia—Bupropion—obesity	0.000225	0.00173	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Topiramate—obesity	0.000225	0.00173	CcSEcCtD
Pomalidomide—Anxiety—Bupropion—obesity	0.000224	0.00173	CcSEcCtD
Pomalidomide—Insomnia—Sibutramine—obesity	0.000224	0.00172	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000224	0.00172	CcSEcCtD
Pomalidomide—ABCB1—digestive system—obesity	0.000223	0.00796	CbGeAlD
Pomalidomide—Decreased appetite—Orlistat—obesity	0.000222	0.00171	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Orlistat—obesity	0.000221	0.0017	CcSEcCtD
Pomalidomide—Dyspnoea—Sibutramine—obesity	0.000221	0.0017	CcSEcCtD
Pomalidomide—Fatigue—Orlistat—obesity	0.000221	0.0017	CcSEcCtD
Pomalidomide—Weight increased—Topiramate—obesity	0.00022	0.00169	CcSEcCtD
Pomalidomide—Weight decreased—Topiramate—obesity	0.000219	0.00168	CcSEcCtD
Pomalidomide—Pain—Orlistat—obesity	0.000219	0.00168	CcSEcCtD
Pomalidomide—Hyperglycaemia—Topiramate—obesity	0.000218	0.00168	CcSEcCtD
Pomalidomide—Confusional state—Bupropion—obesity	0.000218	0.00168	CcSEcCtD
Pomalidomide—Pneumonia—Topiramate—obesity	0.000217	0.00167	CcSEcCtD
Pomalidomide—Infestation NOS—Topiramate—obesity	0.000216	0.00166	CcSEcCtD
Pomalidomide—Infestation—Topiramate—obesity	0.000216	0.00166	CcSEcCtD
Pomalidomide—Decreased appetite—Sibutramine—obesity	0.000215	0.00166	CcSEcCtD
Pomalidomide—Infection—Bupropion—obesity	0.000214	0.00165	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Sibutramine—obesity	0.000214	0.00165	CcSEcCtD
Pomalidomide—ABCB1—adrenal gland—obesity	0.000212	0.00759	CbGeAlD
Pomalidomide—Renal failure—Topiramate—obesity	0.000212	0.00163	CcSEcCtD
Pomalidomide—Pain—Sibutramine—obesity	0.000212	0.00163	CcSEcCtD
Pomalidomide—Constipation—Sibutramine—obesity	0.000212	0.00163	CcSEcCtD
Pomalidomide—Nervous system disorder—Bupropion—obesity	0.000212	0.00163	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Topiramate—obesity	0.000211	0.00163	CcSEcCtD
Pomalidomide—Thrombocytopenia—Bupropion—obesity	0.000211	0.00163	CcSEcCtD
Pomalidomide—Feeling abnormal—Orlistat—obesity	0.000211	0.00162	CcSEcCtD
Pomalidomide—Skin disorder—Bupropion—obesity	0.00021	0.00161	CcSEcCtD
Pomalidomide—Urinary tract infection—Topiramate—obesity	0.00021	0.00161	CcSEcCtD
Pomalidomide—Hyperhidrosis—Bupropion—obesity	0.000209	0.00161	CcSEcCtD
Pomalidomide—Feeling abnormal—Sibutramine—obesity	0.000204	0.00157	CcSEcCtD
Pomalidomide—Epistaxis—Topiramate—obesity	0.000203	0.00157	CcSEcCtD
Pomalidomide—Body temperature increased—Orlistat—obesity	0.000202	0.00156	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Bupropion—obesity	0.000197	0.00151	CcSEcCtD
Pomalidomide—Body temperature increased—Sibutramine—obesity	0.000196	0.00151	CcSEcCtD
Pomalidomide—Insomnia—Bupropion—obesity	0.000195	0.0015	CcSEcCtD
Pomalidomide—Dyspnoea—Bupropion—obesity	0.000192	0.00148	CcSEcCtD
Pomalidomide—Urinary tract disorder—Topiramate—obesity	0.000191	0.00147	CcSEcCtD
Pomalidomide—Oedema peripheral—Topiramate—obesity	0.000191	0.00147	CcSEcCtD
Pomalidomide—Connective tissue disorder—Topiramate—obesity	0.00019	0.00146	CcSEcCtD
Pomalidomide—Urethral disorder—Topiramate—obesity	0.00019	0.00146	CcSEcCtD
Pomalidomide—Hypersensitivity—Orlistat—obesity	0.000188	0.00145	CcSEcCtD
Pomalidomide—Decreased appetite—Bupropion—obesity	0.000188	0.00144	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Bupropion—obesity	0.000186	0.00143	CcSEcCtD
Pomalidomide—Fatigue—Bupropion—obesity	0.000186	0.00143	CcSEcCtD
Pomalidomide—Constipation—Bupropion—obesity	0.000185	0.00142	CcSEcCtD
Pomalidomide—Pain—Bupropion—obesity	0.000185	0.00142	CcSEcCtD
Pomalidomide—ABCB1—endocrine gland—obesity	0.000184	0.00658	CbGeAlD
Pomalidomide—Asthenia—Orlistat—obesity	0.000184	0.00141	CcSEcCtD
Pomalidomide—Hypersensitivity—Sibutramine—obesity	0.000182	0.0014	CcSEcCtD
Pomalidomide—Pruritus—Orlistat—obesity	0.000181	0.00139	CcSEcCtD
Pomalidomide—Cardiac disorder—Topiramate—obesity	0.00018	0.00138	CcSEcCtD
Pomalidomide—Feeling abnormal—Bupropion—obesity	0.000178	0.00137	CcSEcCtD
Pomalidomide—Asthenia—Sibutramine—obesity	0.000178	0.00137	CcSEcCtD
Pomalidomide—Angiopathy—Topiramate—obesity	0.000176	0.00135	CcSEcCtD
Pomalidomide—Pruritus—Sibutramine—obesity	0.000175	0.00135	CcSEcCtD
Pomalidomide—Diarrhoea—Orlistat—obesity	0.000175	0.00135	CcSEcCtD
Pomalidomide—Mediastinal disorder—Topiramate—obesity	0.000174	0.00134	CcSEcCtD
Pomalidomide—Chills—Topiramate—obesity	0.000174	0.00134	CcSEcCtD
Pomalidomide—Body temperature increased—Bupropion—obesity	0.000171	0.00131	CcSEcCtD
Pomalidomide—Mental disorder—Topiramate—obesity	0.00017	0.00131	CcSEcCtD
Pomalidomide—Diarrhoea—Sibutramine—obesity	0.000169	0.0013	CcSEcCtD
Pomalidomide—Dizziness—Orlistat—obesity	0.000169	0.0013	CcSEcCtD
Pomalidomide—Malnutrition—Topiramate—obesity	0.000168	0.0013	CcSEcCtD
Pomalidomide—ABCB1—liver—obesity	0.000166	0.00593	CbGeAlD
Pomalidomide—Dizziness—Sibutramine—obesity	0.000164	0.00126	CcSEcCtD
Pomalidomide—Back pain—Topiramate—obesity	0.000163	0.00125	CcSEcCtD
Pomalidomide—Vomiting—Orlistat—obesity	0.000163	0.00125	CcSEcCtD
Pomalidomide—Muscle spasms—Topiramate—obesity	0.000162	0.00125	CcSEcCtD
Pomalidomide—Rash—Orlistat—obesity	0.000161	0.00124	CcSEcCtD
Pomalidomide—Dermatitis—Orlistat—obesity	0.000161	0.00124	CcSEcCtD
Pomalidomide—Headache—Orlistat—obesity	0.00016	0.00123	CcSEcCtD
Pomalidomide—Hypersensitivity—Bupropion—obesity	0.000159	0.00122	CcSEcCtD
Pomalidomide—Tremor—Topiramate—obesity	0.000158	0.00122	CcSEcCtD
Pomalidomide—Vomiting—Sibutramine—obesity	0.000157	0.00121	CcSEcCtD
Pomalidomide—Rash—Sibutramine—obesity	0.000156	0.0012	CcSEcCtD
Pomalidomide—Dermatitis—Sibutramine—obesity	0.000156	0.0012	CcSEcCtD
Pomalidomide—Anaemia—Topiramate—obesity	0.000156	0.0012	CcSEcCtD
Pomalidomide—Headache—Sibutramine—obesity	0.000155	0.00119	CcSEcCtD
Pomalidomide—Asthenia—Bupropion—obesity	0.000155	0.00119	CcSEcCtD
Pomalidomide—Pruritus—Bupropion—obesity	0.000153	0.00118	CcSEcCtD
Pomalidomide—Nausea—Orlistat—obesity	0.000152	0.00117	CcSEcCtD
Pomalidomide—Vertigo—Topiramate—obesity	0.000151	0.00117	CcSEcCtD
Pomalidomide—Leukopenia—Topiramate—obesity	0.000151	0.00116	CcSEcCtD
Pomalidomide—Diarrhoea—Bupropion—obesity	0.000148	0.00114	CcSEcCtD
Pomalidomide—Nausea—Sibutramine—obesity	0.000147	0.00113	CcSEcCtD
Pomalidomide—Cough—Topiramate—obesity	0.000147	0.00113	CcSEcCtD
Pomalidomide—Arthralgia—Topiramate—obesity	0.000143	0.0011	CcSEcCtD
Pomalidomide—Anxiety—Topiramate—obesity	0.000143	0.0011	CcSEcCtD
Pomalidomide—Dizziness—Bupropion—obesity	0.000143	0.0011	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000142	0.0011	CcSEcCtD
Pomalidomide—Confusional state—Topiramate—obesity	0.000139	0.00107	CcSEcCtD
Pomalidomide—Vomiting—Bupropion—obesity	0.000137	0.00106	CcSEcCtD
Pomalidomide—Infection—Topiramate—obesity	0.000137	0.00105	CcSEcCtD
Pomalidomide—Rash—Bupropion—obesity	0.000136	0.00105	CcSEcCtD
Pomalidomide—Dermatitis—Bupropion—obesity	0.000136	0.00105	CcSEcCtD
Pomalidomide—Headache—Bupropion—obesity	0.000135	0.00104	CcSEcCtD
Pomalidomide—Nervous system disorder—Topiramate—obesity	0.000135	0.00104	CcSEcCtD
Pomalidomide—Thrombocytopenia—Topiramate—obesity	0.000135	0.00104	CcSEcCtD
Pomalidomide—Skin disorder—Topiramate—obesity	0.000134	0.00103	CcSEcCtD
Pomalidomide—Hyperhidrosis—Topiramate—obesity	0.000133	0.00102	CcSEcCtD
Pomalidomide—Nausea—Bupropion—obesity	0.000128	0.000987	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Topiramate—obesity	0.000125	0.000964	CcSEcCtD
Pomalidomide—Insomnia—Topiramate—obesity	0.000124	0.000957	CcSEcCtD
Pomalidomide—Dyspnoea—Topiramate—obesity	0.000123	0.000944	CcSEcCtD
Pomalidomide—Decreased appetite—Topiramate—obesity	0.00012	0.00092	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Topiramate—obesity	0.000119	0.000914	CcSEcCtD
Pomalidomide—Fatigue—Topiramate—obesity	0.000119	0.000913	CcSEcCtD
Pomalidomide—Pain—Topiramate—obesity	0.000118	0.000905	CcSEcCtD
Pomalidomide—Constipation—Topiramate—obesity	0.000118	0.000905	CcSEcCtD
Pomalidomide—Feeling abnormal—Topiramate—obesity	0.000113	0.000872	CcSEcCtD
Pomalidomide—Body temperature increased—Topiramate—obesity	0.000109	0.000837	CcSEcCtD
Pomalidomide—Hypersensitivity—Topiramate—obesity	0.000101	0.00078	CcSEcCtD
Pomalidomide—Asthenia—Topiramate—obesity	9.87e-05	0.000759	CcSEcCtD
Pomalidomide—Pruritus—Topiramate—obesity	9.73e-05	0.000749	CcSEcCtD
Pomalidomide—Diarrhoea—Topiramate—obesity	9.41e-05	0.000724	CcSEcCtD
Pomalidomide—Dizziness—Topiramate—obesity	9.09e-05	0.0007	CcSEcCtD
Pomalidomide—Vomiting—Topiramate—obesity	8.74e-05	0.000673	CcSEcCtD
Pomalidomide—Rash—Topiramate—obesity	8.67e-05	0.000667	CcSEcCtD
Pomalidomide—Dermatitis—Topiramate—obesity	8.66e-05	0.000667	CcSEcCtD
Pomalidomide—Headache—Topiramate—obesity	8.61e-05	0.000663	CcSEcCtD
Pomalidomide—Nausea—Topiramate—obesity	8.17e-05	0.000629	CcSEcCtD
Pomalidomide—ABCB1—Metabolism—APOC3—obesity	7.1e-06	6.75e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPIN1—obesity	7.03e-06	6.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC27A1—obesity	7.01e-06	6.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	6.9e-06	6.56e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CETP—obesity	6.89e-06	6.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA5—obesity	6.88e-06	6.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FABP4—obesity	6.87e-06	6.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GLUL—obesity	6.87e-06	6.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—obesity	6.85e-06	6.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SDC1—obesity	6.82e-06	6.48e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	6.77e-06	6.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRKCD—obesity	6.77e-06	6.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARGC1A—obesity	6.75e-06	6.42e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GNB3—obesity	6.75e-06	6.42e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—obesity	6.72e-06	6.39e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C3—obesity	6.7e-06	6.37e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	6.69e-06	6.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—obesity	6.61e-06	6.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SCARB1—obesity	6.6e-06	6.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GNAS—obesity	6.58e-06	6.25e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC22A1—obesity	6.57e-06	6.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CLOCK—obesity	6.57e-06	6.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	6.55e-06	6.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UCP2—obesity	6.52e-06	6.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ECHS1—obesity	6.52e-06	6.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD11B1—obesity	6.52e-06	6.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UCP3—obesity	6.52e-06	6.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	6.49e-06	6.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	6.48e-06	6.15e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOB—obesity	6.44e-06	6.12e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH1B—obesity	6.41e-06	6.09e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SREBF1—obesity	6.41e-06	6.09e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GLP1R—obesity	6.4e-06	6.08e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SULT2A1—obesity	6.4e-06	6.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPAM—obesity	6.31e-06	6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1B—obesity	6.31e-06	6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACSL1—obesity	6.31e-06	6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DPYD—obesity	6.29e-06	5.98e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS2—obesity	6.29e-06	5.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT2—obesity	6.23e-06	5.92e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—obesity	6.16e-06	5.85e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—obesity	6.15e-06	5.84e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FADS1—obesity	6.13e-06	5.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PCK1—obesity	6.13e-06	5.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HADH—obesity	6.13e-06	5.82e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—obesity	6.11e-06	5.81e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FASN—obesity	6.1e-06	5.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CAV1—obesity	6.1e-06	5.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—obesity	6.08e-06	5.78e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCHE—obesity	6.07e-06	5.77e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRKAR2B—obesity	6.06e-06	5.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DCN—obesity	6.02e-06	5.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—obesity	6e-06	5.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACP5—obesity	5.96e-06	5.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.91e-06	5.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2E1—obesity	5.86e-06	5.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CPT1A—obesity	5.85e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD36—obesity	5.84e-06	5.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PD—obesity	5.81e-06	5.52e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NQO1—obesity	5.79e-06	5.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NAMPT—obesity	5.74e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HK1—obesity	5.74e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF2—obesity	5.74e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BAD—obesity	5.74e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	5.71e-06	5.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LIPC—obesity	5.7e-06	5.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCK—obesity	5.7e-06	5.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOC3—obesity	5.67e-06	5.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	5.63e-06	5.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCG—obesity	5.56e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A4—obesity	5.56e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPA—obesity	5.54e-06	5.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—obesity	5.54e-06	5.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CETP—obesity	5.5e-06	5.23e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS1—obesity	5.49e-06	5.22e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYCS—obesity	5.48e-06	5.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SDC1—obesity	5.44e-06	5.17e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARA—obesity	5.43e-06	5.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPIN1—obesity	5.42e-06	5.15e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT1—obesity	5.38e-06	5.11e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT1—obesity	5.38e-06	5.11e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C3—obesity	5.35e-06	5.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA5—obesity	5.31e-06	5.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOA1—obesity	5.3e-06	5.04e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SCARB1—obesity	5.27e-06	5.01e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—obesity	5.26e-06	5e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—obesity	5.26e-06	5e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STK11—obesity	5.22e-06	4.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP19A1—obesity	5.22e-06	4.96e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.2e-06	4.94e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—obesity	5.16e-06	4.9e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	5.13e-06	4.88e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SREBF1—obesity	5.12e-06	4.86e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAV1—obesity	5.11e-06	4.85e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—obesity	5.1e-06	4.84e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT2—obesity	5.08e-06	4.83e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CLOCK—obesity	5.07e-06	4.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC22A1—obesity	5.07e-06	4.82e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT2—obesity	4.98e-06	4.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GLP1R—obesity	4.94e-06	4.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SULT2A1—obesity	4.94e-06	4.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.91e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CD—obesity	4.88e-06	4.64e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.88e-06	4.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FASN—obesity	4.87e-06	4.63e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DPYD—obesity	4.86e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—obesity	4.86e-06	4.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCHE—obesity	4.85e-06	4.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—obesity	4.83e-06	4.59e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GNB3—obesity	4.79e-06	4.55e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARGC1A—obesity	4.79e-06	4.55e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—obesity	4.77e-06	4.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TYK2—obesity	4.7e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2E1—obesity	4.68e-06	4.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRKAR2B—obesity	4.68e-06	4.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GNAS—obesity	4.66e-06	4.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RHOA—obesity	4.66e-06	4.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CG—obesity	4.65e-06	4.42e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DCN—obesity	4.64e-06	4.41e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NQO1—obesity	4.63e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3R1—obesity	4.61e-06	4.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—obesity	4.61e-06	4.38e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOB—obesity	4.57e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.53e-06	4.3e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CPT1A—obesity	4.52e-06	4.29e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—obesity	4.49e-06	4.27e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.49e-06	4.27e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A4—obesity	4.44e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCG—obesity	4.44e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NAMPT—obesity	4.43e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—obesity	4.43e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—obesity	4.4e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LIPC—obesity	4.4e-06	4.18e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCK—obesity	4.4e-06	4.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYCS—obesity	4.38e-06	4.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOC3—obesity	4.37e-06	4.16e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—obesity	4.36e-06	4.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT1—obesity	4.3e-06	4.08e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT1—obesity	4.3e-06	4.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CB—obesity	4.26e-06	4.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTOR—obesity	4.26e-06	4.05e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—obesity	4.25e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CETP—obesity	4.25e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA1—obesity	4.23e-06	4.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SDC1—obesity	4.2e-06	3.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STK11—obesity	4.17e-06	3.96e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP19A1—obesity	4.17e-06	3.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD36—obesity	4.14e-06	3.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C3—obesity	4.13e-06	3.93e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CD—obesity	4.09e-06	3.89e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SCARB1—obesity	4.07e-06	3.86e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—obesity	4.04e-06	3.84e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF1—obesity	3.95e-06	3.75e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—obesity	3.93e-06	3.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—obesity	3.88e-06	3.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3R1—obesity	3.86e-06	3.67e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—obesity	3.86e-06	3.67e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARA—obesity	3.85e-06	3.66e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT2—obesity	3.84e-06	3.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARGC1A—obesity	3.82e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GNB3—obesity	3.82e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—obesity	3.81e-06	3.62e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FASN—obesity	3.76e-06	3.57e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCHE—obesity	3.74e-06	3.56e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—obesity	3.73e-06	3.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GNAS—obesity	3.72e-06	3.54e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—obesity	3.65e-06	3.47e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOB—obesity	3.64e-06	3.46e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAV1—obesity	3.62e-06	3.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—obesity	3.61e-06	3.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2E1—obesity	3.61e-06	3.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NQO1—obesity	3.57e-06	3.39e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CB—obesity	3.56e-06	3.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—obesity	3.48e-06	3.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCG—obesity	3.42e-06	3.25e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A4—obesity	3.42e-06	3.25e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYCS—obesity	3.38e-06	3.21e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT1—obesity	3.32e-06	3.15e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT1—obesity	3.32e-06	3.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD36—obesity	3.31e-06	3.14e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CG—obesity	3.3e-06	3.13e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA1—obesity	3.27e-06	3.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STK11—obesity	3.22e-06	3.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP19A1—obesity	3.22e-06	3.06e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—obesity	3.18e-06	3.02e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—obesity	3.14e-06	2.98e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—obesity	3.13e-06	2.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—obesity	3.12e-06	2.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARA—obesity	3.07e-06	2.92e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MYC—obesity	3.06e-06	2.9e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—obesity	3.05e-06	2.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—obesity	2.99e-06	2.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—obesity	2.98e-06	2.83e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GNB3—obesity	2.95e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1A—obesity	2.95e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—obesity	2.94e-06	2.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—obesity	2.92e-06	2.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CD—obesity	2.9e-06	2.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAV1—obesity	2.89e-06	2.75e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—obesity	2.88e-06	2.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GNAS—obesity	2.87e-06	2.73e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOB—obesity	2.81e-06	2.67e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.76e-06	2.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3R1—obesity	2.74e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—obesity	2.74e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—obesity	2.69e-06	2.55e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CG—obesity	2.63e-06	2.5e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—obesity	2.62e-06	2.49e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CA—obesity	2.59e-06	2.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD36—obesity	2.55e-06	2.43e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—obesity	2.54e-06	2.41e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CB—obesity	2.53e-06	2.4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—obesity	2.51e-06	2.38e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—obesity	2.49e-06	2.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—obesity	2.42e-06	2.3e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARA—obesity	2.37e-06	2.25e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CD—obesity	2.31e-06	2.2e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—obesity	2.3e-06	2.18e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—obesity	2.3e-06	2.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—obesity	2.28e-06	2.17e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—obesity	2.25e-06	2.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAV1—obesity	2.23e-06	2.12e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—obesity	2.23e-06	2.12e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3R1—obesity	2.19e-06	2.08e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—obesity	2.19e-06	2.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CA—obesity	2.17e-06	2.07e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—obesity	2.12e-06	2.01e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CG—obesity	2.03e-06	1.93e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CB—obesity	2.02e-06	1.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—obesity	2e-06	1.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—obesity	1.96e-06	1.86e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—obesity	1.93e-06	1.84e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—obesity	1.92e-06	1.83e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CD—obesity	1.79e-06	1.7e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—obesity	1.78e-06	1.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—obesity	1.69e-06	1.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3R1—obesity	1.69e-06	1.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CB—obesity	1.56e-06	1.48e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—obesity	1.54e-06	1.47e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CA—obesity	1.54e-06	1.46e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—obesity	1.26e-06	1.2e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CA—obesity	1.23e-06	1.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—obesity	1e-06	9.55e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CA—obesity	9.49e-07	9.02e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—obesity	7.75e-07	7.37e-06	CbGpPWpGaD
